- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Colonial First State Rollover & Superannuation Fund - Global Health & Biotechnol
+ Add to WatchlistCFSGRON:AU
0.97 AUD -0.00-0.17%As of 00:59:30 ET on 05/23/2013.
Snapshot for Colonial First State Rollover & Superannuation Fund - Global Health & Biotechnol (CFSGRON)
| Year To Date: | +29.37% | 3-Month: | +20.25% | 3-Year: | +12.27% | 52-Week Range: | 0.72 - 0.97 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +8.63% | 1-Year: | +31.84% | 5-Year: | +8.22% | Beta vs AS51: | 0.50 |
Fund Profile & Information for CFSGRON
Colonial First State Rollover & Superannuation - Global Health & Biotechnology Option is a superannuation fund incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.
| Inception Date: | 11-23-2001 | Telephone: | 61-2-9273-3000 |
|---|---|---|---|
| Managers: | DAVID L LEARY | ||
| Web Site: | www.colonialfirststate.com.au | ||
Fundamentals for CFSGRON
| NAV | (on 2013-05-23) 0.97 |
|---|---|
| Assets (M) | (on 2013-04-30) 7.79 |
| Fund Leveraged | N |
| Minimum Investment | 1,500.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for CFSGRON
No dividends reported
Fees & Expenses for CFSGRON
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 2.12 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 2.50 |
Top Fund Holdings for CFSGRON
Holding Data Unavailable.
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page